Transgene as vaccine for chlamydia

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Brunham, R C ^a   Zhang, D J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; DRUG EFFICACY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; TRANSGENE;

EID: 0032716557     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70291-7     Document Type: Conference Paper

References (7)

1. Yang X, Brunham RC. T lymphocyte immunity in host defense against Chlamydia trachomatis and its implication for vaccine development. Can J Infect Dis 1998;9:99-109.
2. Grayston JT, Wang SP. The potential for vaccine against infection of the genital tract with Chlamydia trachomatis. Sex Trans Dis 1978;5:73-7.
3. Brunham RC. Vaccine design for the prevention of Chlamydia trachomatis infection. In: Orfila J, Byrne GI, Chernesky MA, et al, editors. Chlamydial infections. Proceedings of the 8th International Symposium on Human Chlamydial Infections. Paris, France: Societa Editrice Esculapio. 1994. p. 73-82.
4. Zhang D, Yang X, Berry J, et al. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 1997;176:1035-40.
5. Zhang DJ, Yang X, Shen C, et al. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis agent. Immunology. 1999;96:314-21.
6. Darji A, Guzman CA, Gerstel B, et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997;91:765-75.
7. Leung KY, Finlay BB. Intracellular replication is essential for the virulence of Salmonella typhimurium. Proc Natl Acad Sci U S A 1991;88:11470-4.